Treatment rates were far higher for those over 50. As a result, ... a researcher who retired from the CDC’s Division of HIV Prevention last year. If the surveys resume, ...

About 54 percent of people living with HIV in the United States are ages 50 and older. By 2030, researchers estimate that this proportion will increase to 70 percent of those living with HIV.

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

A CDC webpage says that in the 2023 fiscal year, Congress appropriated roughly $1.3 billion for the CDC’s HIV, viral hepatitis, STD and tuberculosis prevention budget.

The CDC on Friday is scrubbing a swath of HIV-related content from the agency’s website as a part of Trump’s broader effort to wipe out DEI initiatives.

If enacted, the cuts could impact the $50 million in CDC funding for HIV work in Georgia, which had the second-highest rate of new cases in 2022, according to the CDC’s most recent data.. While ...

Gilead Sciences (NASDAQ:GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and Descovy. The lawsuit stemmed from research Gilead (NASDAQ:GILD ...

Treatment rates were far higher for those over 50. As a result, ... Recent layoffs and reinstatements of CDC HIV experts have disrupted major national HIV surveillance projects, ...

Treatment rates were far higher for those over 50. As a result, ... a researcher who retired from the CDC's Division of HIV Prevention last year. If the surveys resume, ...